- |||||||||| Fycompa (perampanel) / Eisai, Catalyst Pharma
Trial completion: A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents (clinicaltrials.gov) - May 15, 2019 P2, N=133, Completed, Active, not recruiting --> Completed
- |||||||||| topiramate / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date, Surgery: Preventing Brain Injury in Infants With Congenital Heart Disease (clinicaltrials.gov) - Feb 8, 2019 P1, N=24, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jan 2019 --> Jul 2017 | Trial primary completion date: Jan 2019 --> Jul 2017
- |||||||||| lacosamide / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Lacosamide in Preventing Seizures in Participants With Malignant Glioma (clinicaltrials.gov) - Dec 20, 2018 P=N/A, N=37, Terminated, Recruiting --> Completed | N=24 --> 36 N=302 --> 37 | Active, not recruiting --> Terminated | Trial primary completion date: Jul 2018 --> Jun 2017
- |||||||||| Trial completion date: Exercise Education for Adults With Seizure Disorders (clinicaltrials.gov) - Dec 11, 2018
P1, N=30, Completed, N=302 --> 37 | Active, not recruiting --> Terminated | Trial primary completion date: Jul 2018 --> Jun 2017 Trial completion date: Jan 2017 --> Dec 2018
- |||||||||| topiramate / Generic mfg.
Trial completion date, Trial primary completion date, Surgery: Preventing Brain Injury in Infants With Congenital Heart Disease (clinicaltrials.gov) - Oct 18, 2018 P1, N=24, Active, not recruiting, Trial primary completion date: Oct 2015 --> Oct 2017 Trial completion date: Aug 2018 --> Jan 2019 | Trial primary completion date: Aug 2018 --> Jan 2019
- |||||||||| Trial completion: Berlin Magnetic Seizure Therapy Depression Trial 01 (clinicaltrials.gov) - Jul 13, 2018
P3, N=32, Completed, Active, not recruiting --> Terminated; No longer any benefit in collecting data since retigabine has been withdrawn from market. Recruiting --> Completed
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Clinical-genetic Investigations in Children With Early Infantile Epilepsies (clinicaltrials.gov) - Feb 12, 2018
P=N/A, N=75, Completed, N=700 --> 104 Recruiting --> Completed | N=50 --> 75 | Trial primary completion date: Jun 2015 --> Dec 2017 | Trial completion date: Jun 2015 --> Dec 2017
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date, HEOR: STEP: Enhanced Physical Activity in Children and Youth With Epilepsy (clinicaltrials.gov) - Feb 5, 2018
P=N/A, N=122, Active, not recruiting, Recruiting --> Completed | N=50 --> 75 | Trial primary completion date: Jun 2015 --> Dec 2017 | Trial completion date: Jun 2015 --> Dec 2017 Recruiting --> Active, not recruiting | N=200 --> 122 | Trial primary completion date: Mar 2017 --> Mar 2018
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder (clinicaltrials.gov) - Feb 5, 2018
P3, N=53, Completed, Recruiting --> Active, not recruiting | N=200 --> 122 | Trial primary completion date: Mar 2017 --> Mar 2018 Active, not recruiting --> Completed | Trial primary completion date: Jan 2018 --> Jun 2017 | Trial completion date: Jan 2018 --> Jun 2017
- |||||||||| Trial completion: Modified Atkins Diet Plus KetoCal for Adult Epilepsy (clinicaltrials.gov) - Jan 24, 2018
P=N/A, N=80, Completed, Active, not recruiting --> Completed | Trial primary completion date: Oct 2017 --> Oct 2015 Active, not recruiting --> Completed
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures (clinicaltrials.gov) - Dec 20, 2017
P=N/A, N=29, Completed, N=86 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed | N=80 --> 29 | Trial primary completion date: Nov 2016 --> Jan 2016
- |||||||||| Enrollment change, Trial withdrawal, Trial primary completion date: Evaluating the Efficacy of Magnetic Seizure Therapy in Treatment Resistant Depression. (clinicaltrials.gov) - Nov 20, 2017
P=N/A, N=0, Withdrawn, Active, not recruiting --> Completed | N=80 --> 29 | Trial primary completion date: Nov 2016 --> Jan 2016 N=200 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2018 --> Dec 2016
- |||||||||| Phase classification, Enrollment change, Trial termination, Surgery: Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy (clinicaltrials.gov) - Sep 25, 2017
P=N/A, N=3, Terminated, Recruiting --> Completed Phase classification: P4 --> P=N/A | N=120 --> 3 | Not yet recruiting --> Terminated; The study oversight committees unanimously decided to stop the study early on 26/07/2017 due to poor recruitment.
- |||||||||| Trial completion: Copeptin in Childhood Epilepsy (clinicaltrials.gov) - Sep 19, 2017
P=N/A, N=340, Completed, Phase classification: P4 --> P=N/A | N=120 --> 3 | Not yet recruiting --> Terminated; The study oversight committees unanimously decided to stop the study early on 26/07/2017 due to poor recruitment. Active, not recruiting --> Completed
- |||||||||| Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date, Intubation: Early Versus Late Intubation Trial in Physician Manned Emergency Medical Services (clinicaltrials.gov) - Sep 19, 2017
P=N/A, N=0, Withdrawn, Active, not recruiting --> Completed N=500 --> 0 | Initiation date: Sep 2013 --> Jan 2015 | Suspended --> Withdrawn | Trial primary completion date: Dec 2015 --> Mar 2017
- |||||||||| carbamazepine / Generic mfg.
Enrollment change, Adverse drug reaction: Pathogenesis of Adverse Drug Reactions (clinicaltrials.gov) - Aug 14, 2017 P=N/A, N=274, Completed, Trial primary completion date: Dec 2016 --> Apr 2017 N=98 --> 274
|